Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Pulse Biosciences Inc shares valued at $85,238 were sold by Danahy Kevin Patrick on Oct 02 ’25. At $18.53 per share, Danahy Kevin Patrick sold 4,600 shares. The insider’s holdings dropped to 43,298 shares worth approximately $0.64 million following the completion of this transaction.
Also, Danahy Kevin Patrick sold 20,000 shares, netting a total of over 369,800 in proceeds. Following the sale of shares at $18.49 each, the insider now holds 43,298 shares.
Before that, Danahy Kevin Patrick had sold 400 shares from its account. In a trade valued at $7,392, the Chief Commercial Officer traded Pulse Biosciences Inc shares for $18.48 each. Upon closing the transaction, the insider’s holdings decreased to 400 shares, worth approximately $0.64 million.
As published in their initiating research note from Oppenheimer on July 07, 2025, Pulse Biosciences Inc [PLSE] has been an Outperform and the price target has been revised to $22. Analysts at Stephens started covering the stock with ‘”an Overweight”‘ outlook in a report released in late July. As of March 11, 2021, Maxim Group has initiated its “Buy” rating for PLSE. Earlier on January 26, 2021, H.C. Wainwright resumed its rating. Their recommendation was “a Buy” for PLSE stock.
Analyzing PLSE Stock Performance
On last trading session, Pulse Biosciences Inc [NASDAQ: PLSE] rose 1.92% to $14.86. The stock’s lowest price that day was $14.405, but it reached a high of $15.01 in the same session. During the last five days, there has been a surge of approximately 4.21%. Over the course of the year, Pulse Biosciences Inc shares have dropped approximately -17.35%. Shares of the company reached a 52-week high of $25.00 on 02/05/25 and a 52-week low of $12.56 on 11/20/25.
Support And Resistance Levels for Pulse Biosciences Inc (PLSE)
According to the 24-hour chart, there is a support level at 14.51, which, if violated, would cause prices to drop to 14.15. In the upper region, resistance lies at 15.11. The next price resistance is at 15.36. RSI (Relative Strength Index) is 55.29 on the 14-day chart, showing neutral technical sentiment.
Is Pulse Biosciences Inc subject to short interest?
Stocks of Pulse Biosciences Inc saw a sharp rise in short interest on 2025-11-28 jumping by 92908.0 shares to 2.46 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 2.37 million shares. A jump of 3.77% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 14.96 of the overall float, the days-to-cover ratio (short ratio) jumped to 14.96.
Which companies own the most shares of Pulse Biosciences Inc (PLSE)?
On May 12, 2020, H.C. Wainwright assigned a price target of “a Buy” to the stock and upgraded coverage with a $16.
